Advertisement

Management of Colorectal Cancer in Hereditary Syndromes

  • Lisa A. Cunningham
    Affiliations
    Division of Colorectal Surgery, Department of Surgery, The Ohio State University Medical Center, N737B Doan Hall, 410 West 10th Avenue, Columbus, OH 43210, USA
    Search for articles by this author
  • Alessandra Gasior
    Affiliations
    Division of Colorectal Surgery, Department of Surgery, The Ohio State University Medical Center, N737B Doan Hall, 410 West 10th Avenue, Columbus, OH 43210, USA

    Pediatric and Adult Colorectal Surgery, The Ohio State University Medical Center, Nationwide Children’s Hospital, N747 Doan Hall, 410 West 10th Avenue, Columbus, OH 43210, USA
    Search for articles by this author
  • Matthew F. Kalady
    Correspondence
    Corresponding author.
    Affiliations
    Division of Colorectal Surgery, Department of Surgery, The Ohio State University Medical Center, N737B Doan Hall, 410 West 10th Avenue, Columbus, OH 43210, USA

    Clinical Cancer Genetics Program, The James Comprehensive Cancer Center, Columbus, OH 43201, USA
    Search for articles by this author
Published:March 09, 2022DOI:https://doi.org/10.1016/j.soc.2021.11.010

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Oncology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pearlman R.
        • Frankel W.L.
        • Swanson B.J.
        • et al.
        Prospective statewide study of universal screening for hereditary colorectal cancer: the Ohio Colorectal Cancer Prevention Initiative.
        JCO Precis Oncol. 2021; 5 (PO.20.00525)https://doi.org/10.1200/PO.20.00525
        • Kinzler K.W.
        • Nilbert M.C.
        • Su L.K.
        • et al.
        Identification of FAP locus genes from chromosome 5q21.
        Science. 1991; 253: 661-665https://doi.org/10.1126/science.1651562
        • Bisgaard M.L.
        • Fenger K.
        • Bülow S.
        • et al.
        Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate.
        Hum Mutat. 1994; 3: 121-125https://doi.org/10.1002/humu.1380030206
        • Kanth P.
        • Grimmett J.
        • Champine M.
        • et al.
        Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management.
        Am J Gastroenterol. 2017; 112: 1509-1525https://doi.org/10.1038/ajg.2017.212
        • Syngal S.
        • Brand R.E.
        • Church J.M.
        • et al.
        ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes.
        Am J Gastroenterol. 2015; 110: 223-263https://doi.org/10.1038/ajg.2014.435
        • Knudsen A.L.
        • Bülow S.
        • Tomlinson I.
        • et al.
        Attenuated familial adenomatous polyposis: results from an international collaborative study.
        Colorectal Dis. 2010; 12: e243-e249https://doi.org/10.1111/j.1463-1318.2010.02218.x
        • Bülow S.
        • Bülow C.
        • Nielsen T.F.
        • et al.
        Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register.
        Scand J Gastroenterol. 1995; 30: 989-993https://doi.org/10.3109/00365529509096343
        • Sarvepalli S.
        • Burke C.A.
        • Monachese M.
        • et al.
        Web-based model for predicting time to surgery in young patients with familial adenomatous polyposis: an internally validated study.
        Am J Gastroenterol. 2018; 113: 1881-1890https://doi.org/10.1038/s41395-018-0278-2
        • Olsen K.Ø.
        • Juul S.
        • Bülow S.
        • et al.
        Female fecundity before and after operation for familial adenomatous polyposis.
        Br J Surg. 2003; 90: 227-231https://doi.org/10.1002/bjs.4082
        • DE Marchis M.L.
        • Tonelli F.
        • Quaresmini D.
        • et al.
        Desmoid tumors in familial adenomatous polyposis.
        Anticancer Res. 2017; 37: 3357-3366https://doi.org/10.21873/anticanres.11702
        • Elayi E.
        • Manilich E.
        • Church J.
        Polishing the crystal ball: knowing genotype improves ability to predict desmoid disease in patients with familial adenomatous polyposis.
        Dis Colon Rectum. 2009; 52: 1762-1766https://doi.org/10.1007/DCR.0b013e3181b5518a
        • Warrier S.K.
        • Kalady M.F.
        Familial adenomatous polyposis: challenges and pitfalls of surgical treatment.
        Clin Colon Rectal Surg. 2012; 25: 83-89https://doi.org/10.1055/s-0032-1313778
        • Church J.
        • Burke C.
        • McGannon E.
        • et al.
        Predicting polyposis severity by proctoscopy: how reliable is it?.
        Dis Colon Rectum. 2001; 44: 1249-1254https://doi.org/10.1007/BF02234779
        • Slors F.J.
        • van Zuijlen P.P.
        • van Dijk G.J.
        Sexual and bladder dysfunction after total mesorectal excision for benign diseases.
        Scand J Gastroenterol Suppl. 2000; : 48-51
        • Günther K.
        • Braunrieder G.
        • Bittorf B.R.
        • et al.
        Patients with familial adenomatous polyposis experience better bowel function and quality of life after ileorectal anastomosis than after ileoanal pouch.
        Colorectal Dis. 2003; 5: 38-44https://doi.org/10.1046/j.1463-1318.2003.00413.x
        • Sommavilla J.
        • Liska D.
        • Kalady M.
        • et al.
        Ileal Pouch Anal Anastomosis Is More “Desmoidogenic” Than Ileorectal Anastomosis in Familial Adenomatous Polyposis..
        Diseases of the Colon and Rectum. 2021 Nov; https://doi.org/10.1097/dcr.0000000000002172
        • Chittleborough T.J.
        • Warrier S.K.
        • Heriot A.G.
        • et al.
        Dispelling misconceptions in the management of familial adenomatous polyposis.
        ANZ J Surg. 2017; 87: 441-445https://doi.org/10.1111/ans.13919
        • Lovegrove R.E.
        • Constantinides V.A.
        • Heriot A.G.
        • et al.
        A comparison of hand-sewn versus stapled ileal pouch anal anastomosis (IPAA) following proctocolectomy: a meta-analysis of 4183 patients.
        Ann Surg. 2006; 244: 18-26https://doi.org/10.1097/01.sla.0000225031.15405.a3
        • Ozdemir Y.
        • Kalady M.F.
        • Aytac E.
        • et al.
        Anal transitional zone neoplasia in patients with familial adenomatous polyposis after restorative proctocolectomy and IPAA: incidence, management, and oncologic and functional outcomes.
        Dis Colon Rectum. 2013; 56: 808-814https://doi.org/10.1097/DCR.0b013e31829005db
        • Lee C.H.A.
        • Kalady M.F.
        • Burke C.A.
        • et al.
        Incidence and management of rectal cuff and anal transitional zone neoplasia in patients with familial adenomatous polyposis.
        Dis Colon Rectum. 2021; 64: 977-985https://doi.org/10.1097/DCR.0000000000001967
        • Thompson-Fawcett M.W.
        • Marcus V.A.
        • Redston M.
        • et al.
        Adenomatous polyps develop commonly in the ileal pouch of patients with familial adenomatous polyposis.
        Dis Colon Rectum. 2001; 44: 347-353https://doi.org/10.1007/BF02234731
        • Nielsen M.
        • Morreau H.
        • Vasen H.F.
        • et al.
        MUTYH-associated polyposis (MAP).
        Crit Rev Oncol Hematol. 2011; 79: 1-16https://doi.org/10.1016/j.critrevonc.2010.05.011
        • Sampson J.R.
        • Dolwani S.
        • Jones S.
        • et al.
        Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.
        Lancet. 2003; 362: 39-41https://doi.org/10.1016/S0140-6736(03)13805-6
        • Brosens L.A.
        • van Hattem A.
        • Hylind L.M.
        • et al.
        Risk of colorectal cancer in juvenile polyposis.
        Gut. 2007; 56: 965-967
      1. NCCN clinical practice Guidelines in oncology (NCCN Guidelines) peutz-jeghers syndrome screening. Version 1.2015. 2015

        • Pilarski R.
        PTEN hamartoma tumor syndrome: a clinical overview.
        Cancers (Basel). 2019; 11: 844https://doi.org/10.3390/cancers11060844
        • Oncel M.
        • Church J.M.
        • Remzi F.H.
        • et al.
        Colonic surgery in patients with juvenile polyposis syndrome: a case series.
        Dis Colon Rectum. 2005; 48: 49-56https://doi.org/10.1007/s10350-004-0749-y
        • Rosty C.
        • Brosens L.A.A.
        • Nagtegaal I.D.
        Serrated polyposis. WHO classification of tumours.
        Dig Syst Tumours. 2019;
        • IJspeert J.E.
        • Rana S.A.
        • Atkinson N.S.
        • et al.
        Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.
        Gut. 2017; 66: 278-284https://doi.org/10.1136/gutjnl-2015-310630
        • Ashburn J.H.
        • Plesec T.P.
        • Kalady M.F.
        Serrated polyps and serrated polyposis syndrome.
        Clin Colon Rectal Surg. 2016; 29: 336-344https://doi.org/10.1055/s-0036-1584088
        • Vasen H.F.
        • Mecklin J.P.
        • Khan P.M.
        • et al.
        The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC).
        Dis Colon Rectum. 1991; 34: 424-425https://doi.org/10.1007/BF02053699
        • Vasen H.F.
        • Watson P.
        • Mecklin J.P.
        • et al.
        New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC.
        Gastroenterology. 1999; 116: 1453-1456https://doi.org/10.1016/s0016-5085(99)70510-x
        • Leach F.S.
        • Nicolaides N.C.
        • Papadopoulos N.
        • et al.
        Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
        Cell. 1993; 75: 1215-1225https://doi.org/10.1016/0092-8674(93)90330-s
        • Fishel R.
        • Lescoe M.K.
        • Rao M.R.
        • et al.
        The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer [published correction appears in Cell. 1994 Apr 8;77(1):1 p following 166].
        Cell. 1993; 75: 1027-1038https://doi.org/10.1016/0092-8674(93)90546-3
        • Bronner C.E.
        • Baker S.M.
        • Morrison P.T.
        • et al.
        Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.
        Nature. 1994; 368: 258-261https://doi.org/10.1038/368258a0
        • Papadopoulos N.
        • Nicolaides N.C.
        • Wei Y.F.
        • et al.
        Mutation of a mutL homolog in hereditary colon cancer.
        Science. 1994; 263: 1625-1629https://doi.org/10.1126/science.8128251
        • Wijnen J.
        • de Leeuw W.
        • Vasen H.
        • et al.
        Familial endometrial cancer in female carriers of MSH6 germline mutations.
        Nat Genet. 1999; 23: 142-144https://doi.org/10.1038/13773
        • Hampel H.
        • Frankel W.L.
        • Martin E.
        • et al.
        Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
        N Engl J Med. 2005; 352: 1851-1860https://doi.org/10.1056/NEJMoa043146
        • Rubenstein J.H.
        • Enns R.
        • Heidelbaugh J.
        • et al.
        • Clinical Guidelines Committee
        American gastroenterological association institute guideline on the diagnosis and management of lynch syndrome.
        Gastroenterology. 2015; 149: 777https://doi.org/10.1053/j.gastro.2015.07.036
        • Dominguez-Valentin M.
        • Sampson J.R.
        • Seppälä T.T.
        • et al.
        Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database [published correction appears in Genet Med. 2020 Sep;22(9):1569].
        Genet Med. 2020; 22: 15-25https://doi.org/10.1038/s41436-019-0596-9
        • Kobayashi H.
        • Ohno S.
        • Sasaki Y.
        • et al.
        Hereditary breast and ovarian cancer susceptibility genes (review).
        Oncol Rep. 2013; 30: 1019-1029https://doi.org/10.3892/or.2013.2541
        • Møller P.
        • Seppälä T.
        • Bernstein I.
        • et al.
        Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
        Gut. 2017; 66: 464-472https://doi.org/10.1136/gutjnl-2015-309675
        • Järvinen H.J.
        • Aarnio M.
        • Mustonen H.
        • et al.
        Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
        Gastroenterology. 2000; 118: 829-834https://doi.org/10.1016/s0016-5085(00)70168-5
        • Giardiello F.M.
        • Allen J.I.
        • Axilbund J.E.
        • et al.
        Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
        Am J Gastroenterol. 2014; 109: 1159-1179https://doi.org/10.1038/ajg.2014.186
        • Herzig D.
        • Hardiman K.
        • Weiser M.
        • et al.
        The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Inherited Polyposis Syndromes..
        Dis Colon Rectum. 2017 Sep; 60: 881-894
        • Parry S.
        • Win A.K.
        • Parry B.
        • et al.
        Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
        Gut. 2011; 60: 950-957https://doi.org/10.1136/gut.2010.228056
        • Haanstra J.F.
        • de Vos Tot Nederveen Cappel W.H.
        • Gopie J.P.
        • et al.
        Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy.
        Dis Colon Rectum. 2012; 55: 653-659https://doi.org/10.1097/DCR.0b013e31824f5392
        • You Y.N.
        • Chua H.K.
        • Nelson H.
        • et al.
        Segmental vs. extended colectomy: measurable differences in morbidity, function, and quality of life.
        Dis Colon Rectum. 2008; 51: 1036-1043https://doi.org/10.1007/s10350-008-9325-1
        • Kalady M.F.
        • Lipman J.
        • McGannon E.
        • et al.
        Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer.
        Ann Surg. 2012; 255: 1121-1125https://doi.org/10.1097/SLA.0b013e3182565c0b
        • Win A.K.
        • Parry S.
        • Parry B.
        • et al.
        Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers.
        Ann Surg Oncol. 2013; 20: 1829-1836https://doi.org/10.1245/s10434-012-2858-5
        • Parc Y.
        • Zutshi M.
        • Zalinski S.
        • et al.
        Preoperative radiotherapy is associated with worse functional results after coloanal anastomosis for rectal cancer.
        Dis Colon Rectum. 2009; 52: 2004-2014https://doi.org/10.1007/DCR.0b013e3181beb4d8
        • Wertzberger B.E.
        • Sherman S.K.
        • Byrn J.C.
        Differences in short-term outcomes among patients undergoing IPAA with or without preoperative radiation: a National Surgical Quality Improvement Program analysis.
        Dis Colon Rectum. 2014; 57: 1188-1194https://doi.org/10.1097/DCR.0000000000000206
        • Lindor N.M.
        • Rabe K.
        • Petersen G.M.
        • et al.
        Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
        JAMA. 2005; 293: 1979-1985https://doi.org/10.1001/jama.293.16.1979
        • Shiovitz S.
        • Copeland W.K.
        • Passarelli M.N.
        • et al.
        Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.
        Br J Cancer. 2014; 111: 598-602https://doi.org/10.1038/bjc.2014.309
        • Nejadtaghi M.
        • Jafari H.
        • Farrokhi E.
        • et al.
        Familial colorectal cancer type X (FCCTX) and the correlation with various genes-A systematic review.
        Curr Probl Cancer. 2017; 41: 388-397https://doi.org/10.1016/j.currproblcancer.2017.10.002
        • Garre P.
        • Martín L.
        • Bando I.
        • et al.
        Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.
        Fam Cancer. 2014; 13: 109-119https://doi.org/10.1007/s10689-013-9683-2
        • Lindberg L.J.
        • Ladelund S.
        • Frederiksen B.L.
        • et al.
        Outcome of 24 years national surveillance in different hereditary colorectal cancer subgroups leading to more individualised surveillance.
        J Med Genet. 2017; 54: 297-304https://doi.org/10.1136/jmedgenet-2016-104284
        • Mesher D.
        • Dove-Edwin I.
        • Sasieni P.
        • et al.
        A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer.
        Int J Cancer. 2014; 134: 939-947https://doi.org/10.1002/ijc.28397
        • Xu Y.
        • Li C.
        • Zhang Y.
        • et al.
        Comparison between familial colorectal cancer type X and lynch syndrome: molecular, clinical, and pathological characteristics and pedigrees.
        Front Oncol. 2020; 10: 1603https://doi.org/10.3389/fonc.2020.01603